Audit on antibiotic prescriptions in a department of infectious diseases: A prospective and observational survey;Audit des prescriptions antibiotiques dans un service de maladies infectieuses: Enquête prospective observationnelle

Presse Medicale

Volumn 32, Issue 26, 2003, Pages 1208-1212

  Zahar, Jean Ralph ^a   Ghaffari, Parinaz ^b   Kamga, Isabelle ^b   Perronne, Véronique ^b  

^a INSERM   (France)

^b Serv de Med Interne Malad Infect   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; IMIPENEM; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UREIDOPENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG MISUSE; DRUG UTILIZATION; FRANCE; GENERAL PRACTITIONER; HOSPITAL DEPARTMENT; INFECTION; INTERNAL MEDICINE; MEDICAL AUDIT; MEDICAL SOCIETY; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PRESCRIPTION; RESIDENCY EDUCATION; RESIDENT; RESPIRATORY TRACT INFECTION; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; DRUG RESISTANCE, MULTIPLE; FEMALE; FRANCE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0042531545     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wise R, Hart T, Cars O et al. Antimicrobial resistance is a major threat to public health. Br Med J 1998; 317:609-10.
2. Working Party of the British Society for Antimicrobial Chemotherapy. Hospital antibiotic control measures in the UK. Journal of Antimicrobial Chemotherapy. 1994;34:21-42.
3. Gould IM, Jappy B. Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. Journal of Antimicrobial Chemotherapy 1996; 38: 895-904.
4. Bone RC, Grodzin CJ, BalkChest RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112: 235-43.
5. e Conférence de consensus en thérapeutique anti-infectieuse. Les infections ORL. Med Mal Infect 1997; 27 (spécial): 341-54.
6. e Conférence de consensus en thérapeutique anti-infectieuse. Les infections des voies respiratoires Med Mal Infect 1992; 22: 43-50.
7. e Conférence de consensus en thérapeutique anti-infectieuse de la société de pathologie infectieuse en langue française. Prise en charge des infections des voies respiratoires basses. Med Mal Infect 2001; 31:
8. e Conférence de Consensus en Thérapeutique Anti-Infectieuse, Antibiothérapie des infections urinaires. Med Mal Infect 1991; 21: 59-82.
9. e Conférence de consensus en thérapeutique anti-infectieuse. Les infections ostéoarticulaires en dehors des infections à mycobactéries. Med Mal Infect 1991; 20: 37-44.
10. Spilf et Société Française de Dermatologie. Conférence de Consensus. Erysipèle et fasciite nécrosante: prise en charge. Med Mal Infect 2000; 30: 241-5.
11. Maki DG, Schuna AA. A study of antimicrobial misuse in a university hospital. Am J Med Sci 1978; 275: 271-82.
12. Parret T, Schneider R, Rime B, Saghafi L, Pannatier A, Francioli P. Évaluation de l'utilisation des antibiotiques: étude prospective dans un centre hospitalier universitaire. Schweiz Med Wochensch 1993; 123: 403-13.
13. Meehan TP, Fine MJ, Krumholz HM et al. Quality of care, process and outcomes in ederly patients with pneumonia. JAMA 1997; 278: 2082-4.
14. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate treatment of bloodstream infections on patient outcomes in ICU setting. Chest 2000; 118: 146-55.
15. Lewis MA, Kuhl-Habich D, Von Rosen J. Drug use and adverse event monitoring in germen children. Int J Clin Pharmacol Ther 2001; 31: 507-12.
16. Moleski R, Andriole V. Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Rev Infect Dis 1986; 8: 488-93.
17. Schlesinger Y, Paltiel O, Yinnon AM. Analysis and impact of infectious disease consultations in a general hospital. J Hospital Infect 1998; 40: 39-46.
18. Thuong M, Shortgen F, Zazempa V, Girou E, Soussy CJ, Brun-Buisson C. Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation. J Antimicrob Chemother 2000; 46: 501-8.
19. Cabana MD, Rand SC, Powe NR et al. Why don't physicians follow clinical practice guidelines A framework for improvement. JAMA 1999; 282: 1458-65.
20. Frank MO, Batteiger BE, Sorrensen SJ et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care 1997; 5: 180-8.
21. Fowler VG, Sanders LL, Sexton DJ et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27: 478-86.
22. Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato BS. Antibiotic optimization An evaluation of patient safety and economic outcomes. Arch Intern Med 1997; 157: 1689-94.
23. Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: The non pharmalogicologic basis of therapeutics. Ann Intern Med 2000; 133: 128-35.